IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will present an abstract at the IBAGS XIV triennial meeting, held on June 13-16, 2023, in Stockholm, Sweden.
IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will present an abstract at the IBAGS XIV triennial meeting, held on June 13-16, 2023, in Stockholm, Sweden.